Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
3.760
-0.080 (-2.08%)
Feb 11, 2026, 4:00 PM EST - Market closed
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $477.19 million as of February 12, 2026. Its market cap has increased by 6.61% in one year.
Market Cap
477.19M
Enterprise Value
454.25M
1-Year Change
6.61%
Ranking
Category
Stock Price
$3.76
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $477.19M, a decrease of -61.40%. That is a compound annual growth rate of -12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 477.19M | -27.41% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAge Labs | 842.98M |
| Esperion Therapeutics | 798.11M |
| Ironwood Pharmaceuticals | 746.69M |
| Emergent BioSolutions | 579.82M |
| SIGA Technologies | 478.36M |
| Kamada | 477.13M |
| Aquestive Therapeutics | 470.93M |
| Canopy Growth | 415.91M |